Eurofins Scientific SE
ERF.PA
Get informed when a big investor buys or sells
+ FollowMarket Cap$14.6B
Close$
$58.23
24.5% downside
Current Fair Value
24.5% downsideOvervalued by 24.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $14.60 Billion |
|---|---|
| Enterprise Value | $19.64 Billion |
| Dividend Yield | $0.72 (0.93%) |
| Earnings per Share | $2.64 |
| Beta | 0.81 |
| Outstanding Shares | 175,500,000 |
Return
| Return on Equity | 24.03% |
|---|---|
| Return on Assets | 7.83% |
| Return on Invested Capital | 18.83% |
Valuation & Multiples
| P/E Ratio | 25.71 |
|---|---|
| PEG | 114.43 |
| Price to Sales | 1.07 |
| Price to Book Ratio | 3.86 |
| Enterprise Value to Revenue | 1.54 |
| Enterprise Value to EBIT | 12.1 |
| Enterprise Value to Net Income | 22 |
| Total Debt to Enterprise | 0.29 |
| Debt to Equity | 1.56 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 23, 2026
EPS Estimate
$1.91
Average shareholder expectationRevenue Estimate
$3.70 B
Average shareholder expectationNext Earnings Call
Expected Date
March 2, 2027
EPS Estimate
$1.61
Average shareholder expectationRevenue Estimate
$3.79 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Eurofins Scientific SE
65,000 employees
CEO: Gilles G. Martin Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental ...